Author

Nathan Schneider

University of Minnesota

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Aimee Renaud· 1 shared Anthony R. BrauniD· 1 shared Elly E. LiaoiD· 1 shared James R. DuttoniD· 1 shared Jonathan N. SachsiD· 1 shared Nagamani VunnamiD· 1 shared Noah Nathan KocheniD· 1 shared Sophia ZafariiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Aimee Renaud

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

From anti-fungal to potential neurotherapeutic: Posaconazole as an effective inhibitor of cellular TDP-43 pathology

Noah Nathan Kochen, Sophia Zafari, Aimee Renaud, Nathan Schneider, Nagamani Vunnam, Elly E. Liao, James R. Dutton, Anthony R. Braun, Jonathan N. Sachs

This study identifies posaconazole as a more effective and safer alternative to ketoconazole for inhibiting TDP-43 pathology in ALS/FTD by reducing aggregation and restoring SREBP2 levels.

bioRxiv · Jun 4, 2026 · PreprintCell Biology